The Florida Department of Business and Professional
Regulation has reached an agreement with Ameridose LLC to temporarily halt
all shipments to facilities in Florida.
Ameridose’s management is associated with the New England Compounding Center,
which is the compounding pharmacy linked to the ongoing outbreak of fungal
meningitis from contaminated medications.On Oct. 31, Ameridose issued a voluntary recall of its unexpired products in circulation. Health care professionals should cease using any products from Ameridose at this time and should return the products to the company.
Facilities with Ameridose products, which may include hospitals, clinics and other establishments, should contact the company at 888-820-0622 for instructions on how to return the products. A complete list of recalled products subject to this recall is available on the company's website.
Continue reading here
No comments:
Post a Comment